Our Science
Targeted. Powerful. Designed to Heal —
Not Harm.
A theranostic platform unlocking the full potential of precision medicine.
At GAIASO, we believe a new era of theranostics is just beginning. The life-changing impact of approved treatments have literally saved lives.
Our approach is designed from target to patient — combining deep biological insights with tailored molecular designs to bring innovations swiftly to the clinic and market.
By leveraging novel isotopes, pursuing new therapeutic targets, and refining our understanding of disease biology, we unify complementary capabilities to deliver truly transformative outcomes.
What sets us apart
Powered by Affilin®: precision by design.
GAIASO’s platform is built on modular Affilin® scaffolds. These small, stable binders are engineered for specificity and flexibility. They enable rapid development, high tumour selectivity, and seamless integration of imaging and therapy.
Affilin® ligands can be efficiently paired with PET tracers or a range of therapeutic isotopes depending on specific needs. The system is made to adapt quickly and deliver precise results where they are needed most.
Developed with Navigo Proteins, the platform produces ligands tailored to the biology of female cancers — enabling personalised care through combined diagnostics and therapy.
Want to get in touch?
Fill out our form and we'll get back to you shortly.
* Please note, all fields are mandatory
Prefer E-Mail? You can reach us directly at [email protected]
"*" indicates required fields